Left ventricular cavitary geometry and dynamic intracavitary left ventricular obstruction during dobutamine stress echocardiography. 1996

Y Hashimoto, and C L Reid, and J M Gardin
Department of Medicine, University of California, Irvine, USA.

To investigate the relationship between left ventricular cavity geometry and dynamic intracavitary left ventricular obstruction occurring during dobutamine stress echocardiography, we evaluated 44 patients who underwent dobutamine stress echocardiography. Dynamic intracavitary left ventricular obstruction appeared in 10 (23%) patients (Group 1), and was absent in the remaining 34 patients (Group 2), during dobutamine stress echocardiography. The ratio of the apicalto-narrowest mid-left ventricular minor-axis dimension (D1/D2), as an index of the left ventricular cavitary geometry, was measured in the baseline two dimensional apical long-axis view. The left ventricular out-flow blood Doppler velocity was measured in the apical long-axis or five-chamber view at each stage during dobutamine infusion. Left ventricular end-systolic dimension was smaller (21 +/- 4 mm v 29 +/- 6 mm; p< .01), percent fractional shortening of the left ventricle was greater (51 +/- 4% v 39 +/- 8%, P>.01), and D1/D2 was greater (1.13 +/- 0.08 v.0.96 +/- 0.09; p < .0001) in Group 1 than in Group 2 in the baseline echocardiogram. Maximal out flow blood Doppler velocity during dobutamine infusion correlated moderately with percent fractional shortening of the left ventricle (r = .53; P < .01) and D1/D2 (r = .60; P < .0001). Dynamic intracavitary left ventricular obstruction, defined as an elevated intracavitary Doppler flow velocity with late-systolic peaking, was not related to the presence of left ventricular hypertrophy or the development of hypotension during dobutamine infusion. We conclude that dynamic left ventricular intracavitary obstruction during dobutamine infusion is associated with a characteristic (narrower-waisted) left ventricular cavitary geometry and increased contractility.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D004280 Dobutamine A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY. Dobucor,Dobuject,Dobutamin Fresenius,Dobutamin Hexal,Dobutamin Solvay,Dobutamin-ratiopharm,Dobutamina Inibsa,Dobutamina Rovi,Dobutamine (+)-Isomer,Dobutamine Hydrobromide,Dobutamine Hydrochloride,Dobutamine Lactobionate,Dobutamine Phosphate (1:1) Salt, (-)-Isomer,Dobutamine Tartrate,Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer,Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer,Dobutamine, (-)-Isomer,Dobutamine, Phosphate (1:1) Salt (+)-Isomer,Dobutrex,Lilly 81929,Oxiken,Posiject,Dobutamin ratiopharm,Hydrobromide, Dobutamine,Hydrochloride, Dobutamine,Lactobionate, Dobutamine,Tartrate, Dobutamine
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Y Hashimoto, and C L Reid, and J M Gardin
September 2001, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology,
Y Hashimoto, and C L Reid, and J M Gardin
September 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography,
Y Hashimoto, and C L Reid, and J M Gardin
November 1992, Circulation,
Y Hashimoto, and C L Reid, and J M Gardin
March 2002, Revista espanola de cardiologia,
Y Hashimoto, and C L Reid, and J M Gardin
October 2002, Journal of the American College of Cardiology,
Copied contents to your clipboard!